Figure 2From: Discovery and SAR exploration of N-aryl-N-(3-aryl-1,2,4-oxadiazol-5-yl)amines as potential therapeutic agents for prostate cancerExamples of inactive or poorly active (% inhibition < 20% at 10 μM) compounds 2.Back to article page